CNS & Neurological Disorders-Drug Targets

Papers
(The TQCC of CNS & Neurological Disorders-Drug Targets is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Meet the Editorial Board Member67
Beyond Dopamine: Novel Therapeutic Pathways for Parkinson's Disease Through Receptor Signaling63
Hypoxia-inducible Factor-1α Pathway in Cerebral Ischemia: From Molecular Mechanisms to Therapeutic Targets44
Meet the Editorial Board Member38
Meet the Editorial Board Member36
Acetylcholinesterase Enzyme Inhibitor Molecules with Therapeutic Potential for Alzheimer's Disease32
Migraine and Obesity: Is There a Relationship? A Systematic Review and Meta-Analysis of Observational Studies25
Deciphering the Role of Peroxisome Proliferator-activated Receptor α and Phosphodiesterase Type 5 Targets in Alzheimer's Disease24
Dopamine Depletion in Parkinson’s Disease and Therapeutic Options23
Traumatic Brain Injury in COVID-19 Patients with the Manifestation of Paroxysmal Sympathetic Hyperactivity and Cytokine Storm22
The Potential Effect of Blueberry on Cognitive Health and Mood State based on Human Intervention Studies: Systematic Review and Mini Meta-Analysis20
Neurobiology of Amphetamine use in Stroke Recovery Combined with Rehabilitative Training and Brain Stimulation20
Emerging Nanotechnology for the Treatment of Alzheimer’s Disease19
A Review on Autism Spectrum Disorder: Pathogenesis, Biomarkers, Pharmacological and Non-Pharmacological Interventions18
Meet the Editorial Board Member18
Emerging Promise of Phytochemicals in Ameliorating Neurological Disorders17
Meet the Editorial Board Member17
Meet the Regional Editor17
The Peripheral Profile of the Chitinase 3-like-1 in Benign Multiple Sclerosis – A Single Centre’s Experience17
Meet Our Editorial Board Member17
Herbal Drug Interaction: Mechanistic Details through Pharmacokinetic Portfolio17
Evaluation of Associated Genes with Traumatic Pain: A Systematic Review16
Drosophila melanogaster a Versatile Model of Parkinson’s Disease16
Crosstalk between SARS-CoV-2 Infection and Neurological Disorders: A Review16
A Comprehensive Review on Therapeutic Potential of Chrysin in Brain Related Disorders16
Atorvastatin Prevents the Neuron Loss in the Hippocampal Dentate Gyrus Region through its Anti-Oxidant and Anti-Apoptotic Activities16
Chemical Kindling as an Experimental Model to Assess the Conventional Drugs in the Treatment of Post-traumatic Epilepsy16
Therapeutic Viewpoint on Rat Models of Locomotion Abnormalities and Neurobiological Indicators in Parkinson's Disease16
CRISPR/Cas9 Gene Editing: A Novel Approach Towards Alzheimer's Disease Treatment16
The Natural Neuroprotective Compounds Used in the 6-Hydroxydopamine- Induced Parkinson’s Disease in Zebrafish: The Current Applications and Perspectives16
Modulation of Huntington’s Disease in Drosophila15
Application of Herbs and Dietary Supplements in ADHD Management15
Update on Oxytocin, Phosphodiesterase, Neurokinin, Glycine as a Therapeutic Approach in the Treatment of Schizophrenia15
Barbigerone against Lipopolysaccharide-Induced Memory Deficit in Rodents via Alteration of Inflammatory and Oxidative Stress Pathway: In vivo and Molecular Dynamics Simulations Study14
Conifer Essential Oils Reversed Amyloid Beta1-42 Action by Modulating BDNF and ARC Expression in The Rat Hippocampus14
Targeted Delivery of Montelukast for the Treatment of Alzheimer’s Disease14
Recent Trends in Physical Therapy Interventions and Neuromodulation Techniques to Improve Neurorehabilitation14
Restless Leg Syndrome in Patients with Liver Cirrhosis! Its Frequency, Severity, and Correlation13
Nanotechnological Advances in the Treatment of Epilepsy13
The Current Evidence for the Therapeutic Role of Curcumin in Alzheimer’s Disease13
Prospective Role of Polyphenolic Compounds in the Treatment of Neurodegenerative Diseases13
Nutrition, Immunity and Aging: Current Scenario and Future Perspectives in Neurodegenerative Diseases13
Mycotoxins and Amyotrophic Lateral Sclerosis: Food Exposure, Nutritional Implications and Dietary Solutions13
A Review of Clinical Studies Assessing the Therapeutic Efficacy of Escitalopram: A Step Towards Development12
Endophenotypes and Pathway Phenotypes in Neuro-psychiatry: Crossdisciplinary Implications for Diagnosis12
Rolipram Rescues Memory Consolidation Deficits Caused by Sleep Deprivation: Implication of the cAMP/PKA and cAMP/Epac Pathways12
Herbal Approaches in the Management of Mental Depression12
Magic Shotgun Nature with Scattergun Approach of Curcumin Repurposing in Obsessive-compulsive Disorder: A Novel Metaphysician of Drug Discovery12
The Use of Midazolam as an Antiseizure Medication in Neonatal Seizures: Single Center Experience and Literature Review12
Cellular Senescence and ApoE4: Their Repercussions in Alzheimer’s Disease12
Arachidonic Acid Metabolites in Neurologic Disorders12
The Role of Glial Cells in Autism Spectrum Disorder: Molecular Mechanisms and Therapeutic Approaches12
Ablation of Shank1 Protects against 6-OHDA-induced Cytotoxicity via PRDX3-mediated Inhibition of ER Stress in SN4741 Cells11
Na+/HCO3− Co-transporters Inhibitor S0859 Attenuates Global Cerebral Ischemia-reperfusion Injury of the CA1 Neurons in the Gerbil’s Hippocampus11
Recent Trends in Nano-Particulate Carriers for the Diagnosis and Treatment of Alzheimer’s Disease11
Effects of α7 Nicotinic Acetylcholine Receptor Positive Allosteric Modulator on BDNF, NKCC1 and KCC2 Expression in the Hippocampus following Lipopolysaccharide-Induced Allodynia and Hyperalgesia in a 11
Mini-Review on SARS-CoV-2 Infection and Neurological Manifestations: A Perspective11
Anti-seizure Medications: Challenges and Opportunities11
Biomarker Validation of a New Case Definition of Menstrual Cycle-Associated Syndrome (MCAS) Opinion Paper11
Dietary Xylitol Supplement Ameliorated AD-related Neuronal Injury by Regulating Glucose Metabolism Relevant Amino Acids in Mice11
Decoding the Inter-Relationship between Sleep Disorders and Alzheimer’s Disease Pathogenesis11
The Role of Monoamine Oxidase B Inhibitors in the Treatment of Parkinson’s Disease - An Update10
Role of Vitamins in Neurodegenerative Diseases: A Review10
Memory Reflections of the Microbiota-Gut and Oligodendrocyte Axis10
Rationale and Development of Tavapadon, a D1/D5-Selective Partial Dopamine Agonist for the Treatment of Parkinson’s Disease10
MCC950 Reduces Neuronal Apoptosis in Spinal Cord Injury in Mice10
Impact of Dimethylfumarate on Sleep in Multiple Sclerosis Patients: An Actigraphic Study10
Pharmacotherapeutic Potential of Garlic in Age-Related Neurological Disorders10
Mini Review on Cariprazine: A Promising Antipsychotic Agent10
Neuroblastoma and Stem Cell Therapy: An Updated Review9
Identification of Known Flavonoids of Ficus carica L. as Aldose Reductase Inhibitors in Sciatic Nerve of Diabetic Neuropathy-induced Rats through Bioinformatics and Proteomics Analysis9
Hypomyelination with Atrophy of Basal Ganglia and Cerebellum (HABC) Due to UFM1 Mutation in Roma Patients - Severe Early Encephalopathy with Stridor and Severe Hearing and Visual Impairment. A Single 9
Acute Phenobarbital Poisoning for the Management of Seizures in Newborns and Children; A Systematic Literature Review9
A New Paradigm in Spinal Cord Injury Therapy: from Cell-free Treatment to Engineering Modifications9
Therapeutic Potential of Myricetin in the Treatment of Neurological, Neuropsychiatric, and Neurodegenerative Disorders9
Alzheimer Disease and Sleep Disorders: Insights into the Possible Disease Connections and the Potential Therapeutic Targets (Part II)9
Immunotherapy for Pediatric Gliomas: CAR-T Cells Against B7H3: A Review of the Literature9
Circadian Rhythms and Sleep Disorders Associated to Major Depressive Disorder: Pathophysiology and Therapeutic Opportunities9
The Protective Role of L-carnitine on Psychosocial Stress-induced Changes in Gene Expression and Protein Levels of Matrix Metalloproteinases, Serum Corticosterone in a Rat Model8
Design and Molecular Docking Studies of N-Mannich Base Derivatives of Primaquine Bearing Isatin on the Targets involved in the Pathophysiology of Cerebral Malaria8
Meet the Editorial Board Member8
Current Drug Targets in Alzheimer’s Associated Memory Impairment: A Comprehensive Review8
Evaluating the Potential of Light Exposure on Reducing the Frequency of Epileptic Seizures8
Meet Our Regional Editor8
Unraveling the Role of Neuroligin3 in Autism Spectrum Disorders: Pathophysiological Insights and Targeted Therapies7
LRRK2; Communicative Role in the Treatment of Parkinson’s Disease and Ulcerative Colitis Overlapping7
Neurological Manifestations of COVID-19 and the Importance of Magnetic Resonance Imaging7
Dioclea Altissima Seed Lectin (DAL) Prevents Anxiety-like Behavioral Responses in Adult Zebrafish (Danio Rerio): Involvement of GABAergic and 5-HT Systems7
New Insights into the Relationship between Nutrition and Neuroinflammation in Alzheimer's Disease: Preventive and Therapeutic Perspectives7
Nanoparticles as Powerful Tools for Crossing the Blood-brain Barrier7
Neurological Complications Caused by Human Immunodeficiency Virus (HIV) and Associated Opportunistic Co-infections: A Review on their Diagnosis and Therapeutic Insights7
Cholinesterase Inhibitory and In Silico Toxicity Assessment of Thirty-Four Isoquinoline Alkaloids - Berberine as the Lead Compound7
Sleep-Related Disorders in Parkinson's Disease: Mechanisms, Diagnosis, and Therapeutic Approaches7
A Review of Antidepressant Effects and Mechanisms of Three Common Herbal Medicines: Panax ginseng, Bupleurum chinense, and Gastrodia elata7
Treatment of Catatonia with Asenapine in a Patient with Schizotypal Personality Disorder, Psychotic Depression and Septic Shock from SARSCoV- 2 - A Case Report7
Neuroprotective Efficacy of Edaravone against Arsenic-Induced Behavioral and Neurochemical Deficits in Rats: Amelioration of Cholinergic and Mitochondrial Functions7
Link of COVID-19 and Neurodegenerative Disorders7
Mechanistic Study on the Possible Role of Embelin in Treating Neurodegenerative Disorders7
Importance of Pharmacophore in Designing Anticonvulsant Agents7
Immunotherapeutics for AD: A Work in Progress7
Transdermal Nutraceuticals Delivery System for CNS Disease7
Treatment and Management of Autosomal Recessive Cerebellar Ataxias: Current Advances and Future Perspectives7
Meet the Editorial Board Member7
Implication of Covid-19 on Neurological Complications with Specific Emphasis on Alzheimer’s and Parkinson’s Disease7
Strategic Approaches to Target the Enzymes using Natural Compounds for the Management of Alzheimer’s Disease: A Review7
Comparison of Safety and Effectiveness between Levetiracetam and Phenytoin in the Treatment of Pediatric Status Epilepticus: A Meta- Analysis7
Recent Advancement of Pyrazole Scaffold Based Neuroprotective Agents: A Review6
Molecular and Biochemical Pathways Encompassing Diabetes Mellitus and Dementia6
GluN2B/N-methyl-D-aspartate Receptor Antagonists: Advances in Design, Synthesis, and Pharmacological Evaluation Studies6
GFAP and UCHL1 in Non-traumatic SAH: The Story thus Far. A Systematic Review of the Literature6
The Alpha-7 Nicotinic Receptor Positive Allosteric Modulator PNU120596 Attenuates Lipopolysaccharide-Induced Depressive-Like Behaviors and Cognitive Impairment by Regulating the PPAR-α Signaling Pathw6
Does Human Alpha-Synuclein Behave Like Prions?6
G Protein-coupled Receptors (GPCRs) as Potential Therapeutics for Psychiatric Disorders6
An Insight into the Role of Artificial Intelligence in the Early Diagnosis of Alzheimer’s Disease6
T Lymphocyte Interferon-gamma Response to Anaplasmataceae-related Major Surface Proteins and Ankyrin A in Fibromyalgia6
Neurotrophin-3 Rescues Striatal Synaptic Plasticity in Model of Neurodegeneration by PLC Signaling Activation6
Bumetanide, a Diuretic That Can Help Children with Autism Spectrum Disorder6
BBBper: A Machine Learning-based Online Tool for Blood-Brain Barrier (BBB) Permeability Prediction6
Navigating into the Paradigm of Nose-to-brain Delivery of Nanotherapeutics and their Repurposing as Nanotheranostics for Neurodegenerative Diseases6
Amelioration of Neurochemical Alteration and Memory and Depressive Behavior in Sepsis by Allopurinol, a Tryptophan 2,3-Dioxygenase Inhibitor6
Effect of Natural Plant Products on Alzheimer’s Disease6
Pharmacogenetics of Carbamazepine: A Systematic Review on CYP3A4 and CYP3A5 Polymorphisms6
Neurokinin-1 Receptor Antagonist Reverses Functional CNS Alteration Caused by Combined γ-rays and Carbon Nuclei Irradiation5
The Impact of ROS and NGF in the Gliomagenesis and their Emerging Implications in the Glioma Treatment5
Elucidations of Molecular Mechanism and Mechanistic Effects of Environmental Toxicants in Neurological Disorders5
Emergence of Sexual Dreams and Emission Following Deep Transcranial Magnetic Stimulation over the Medial Prefrontal and Cingulate Cortices5
Modifiable Risk Factors Associated with Alzheimer’s Disease with Special Reference to Sleep Disturbance5
Deciphering the Influence of Cigarette Smoke Carcinogens on CNS Associated Biomolecules: A Computational Synergistic Approach5
Genetic Causes of Alzheimer’s Disease and the Neuroprotective Role of Melatonin in its Management5
Importance of Exploring N-Methyl-D-Aspartate (NMDA) as a Future Perspective Target in Depression5
Beta-Caryophyllene, a CB2R Selective Agonist, Protects Against Cognitive Impairment Caused by Neuro-inflammation and Not in Dementia Due to Ageing Induced by Mitochondrial Dysfunction5
Intracerebral Hemorrhage and Diabetes Mellitus: Blood-Brain Barrier Disruption, Pathophysiology and Cognitive Impairments5
Towards a Systemic Concept of the Brain Ishemia Stroke: Monte Carlo Driven in silico Model5
Circular RNAs in Alzheimer’s Disease: A New Perspective of Diagnostic and Therapeutic Targets5
Role of Natural Plant Products Against Alzheimer’s Disease5
Regulatory Role of Chinese Herbal Medicine in Regulated Neuronal Death5
Gut-Brain Axis and Neurological Disorders-How Microbiomes Affect our Mental Health5
Amyloid Beta Peptide-Mediated Alterations in Mitochondrial Dynamics and its Implications for Alzheimer’s Disease5
Melatonin Alleviates Pyroptosis of Retinal Neurons Following Acute Intraocular Hypertension5
Nordihydroguaiaretic Acid Affects Undifferentiated and Differentiated Neuroblastoma Cells Differently through Mechanisms that Impact on Cell Viability5
Danshensu Enhances Cerebral Angiogenesis in Mice by Regulating the PI3K/Akt/Mtor/VEGF Signaling Axis5
Monoamine Oxidase: A Potential Link in Papez Circuit to Generalized Anxiety Disorders5
The Emerging Role of Marine Natural Products for the Treatment of Parkinson’s Disease5
Neuroregenerative Activity of the Dipeptide Mimetic of Brain-derived Neurotrophic Factor GSB-106 Under Experimental Ischemic Stroke5
Exploring the Pharmacological Effects of Bioactive Peptides on Human Nervous Disorders: A Comprehensive Review5
Nicotine Abuse and Neurodegeneration: Novel Pharmacogenetic Targets to Aid Quitting and Reduce the Risk of Dementia5
Immunotherapies for Parkinson’s Disease: Progression of Clinical Development5
0.14031910896301